APO-CLINDAMYCIN

I appreciate the detailed instructions, but

I must note an important issue with the source documents provided.

The documents contain information about two different medicines:

1. **ACNATAC** (clindamycin phosphate 1% + tretinoin 0.025% topical gel) — a combination product for acne, sponsored by Viatris 2. **APO-CLINDAMYCIN** (clindamycin hydrochloride 150 mg capsules) — an oral antibiotic, sponsored by Arrotex Pharmaceuticals

The user has requested a Brand Dossier for **APO-CLINDAMYCIN**, but the detailed product information document (Document 1) is for ACNATAC, not APO-CLINDAMYCIN.

Documents 2 and 3 provide only minimal information about APO-CLINDAMYCIN: — ARTG registration number and date — PBS listing details (strength, item count, restriction type, price)

**I cannot write a complete Brand Dossier for APO-CLINDAMYCIN** because the source documents lack the clinical information necessary to populate most of the required sections (approved indications, dosing overview, key safety warnings, contraindications, regulatory history). The product information document provided is for a different medicine entirely.

To proceed, I would need: — The actual product information document for APO-CLINDAMYCIN capsules, or — Clarification that the dossier should be for ACNATAC instead

Please advise which medicine the dossier should cover, and provide the appropriate source documents.